Papers By The 25% M.E Group Patrons, Trustees & Advisers
Purpose This document explains how bone pain can occur in Myalgic Encephalomyelitis (ME), outlining the possible underlying mechanisms and how it fits within the broader pattern of neuroimmune and metabolic dysfunction associated with the condition. Key Points 1. Bone Pain as a Secondary Symptom Bone pain is not considered a primary diagnostic feature of ME….
Purpose This document explains the role of neurological examination in the assessment of individuals with suspected Myalgic Encephalomyelitis (ME/CFS). It outlines what a neurological exam involves, why it is important, and how it can help identify neurological dysfunction associated with the condition. Key Points 1. What a Neurological Examination Is A neurological examination is a…
Purpose This document explains the cardiovascular and circulatory symptoms associated with Myalgic Encephalomyelitis (ME), focusing on how autonomic dysfunction, reduced blood volume, and impaired circulation affect heart function and overall physical stability. Key Points 1. Nature of Cardiovascular Dysfunction Cardiovascular symptoms in ME are primarily related to autonomic nervous system dysfunction. The body struggles to…
Purpose This document explains how Myalgic Encephalomyelitis (ME) affects the brain and central nervous system, highlighting the role of possible viral involvement and the resulting neurological, cognitive, and autonomic dysfunctions that define the condition. Key Points 1. Core Nature of ME ME is described as a disease involving significant disruption to the central nervous system….
Purpose This document explains the musculoskeletal and neuromuscular impairments associated with Myalgic Encephalomyelitis (ME), as defined by the International Consensus Criteria (ICC). It highlights how these symptoms relate to broader neurological and immune dysfunction and outlines supportive management approaches. Key Points 1. Nature of Musculoskeletal and Neuromuscular Impairment These impairments are considered part of the…
Purpose This document explains the hypothesis that persistent enterovirus infection may play a role in Myalgic Encephalomyelitis (ME). It outlines how an initial viral infection could lead to long-term immune disruption, ongoing inflammation, and the wide range of symptoms seen in the condition. Key Points 1. Initial Viral Infection ME may begin after an acute…
Purpose This document explains the role of the gut in Myalgic Encephalomyelitis (ME), highlighting how gut dysfunction interacts with the immune system, brain, and energy metabolism. It outlines how disturbances in gut health can contribute to key symptoms of the condition. Key Points 1. Immune Dysfunction and Gut Dysbiosis Many people with ME show imbalances…
Purpose This document outlines the cardiovascular abnormalities observed in Myalgic Encephalomyelitis (ME), explaining how autonomic dysfunction, reduced blood volume, and impaired energy metabolism affect heart function. It also highlights how these irregularities contribute to key symptoms and provides guidance for monitoring and management. Key Points 1. Nature of Cardiac Dysfunction in ME Cardiac issues…
Purpose This document explains the role of the lymphatic system in Myalgic Encephalomyelitis (ME), highlighting how dysfunction within this system contributes to symptoms such as fatigue, inflammation, cognitive impairment, and post‑exertional crashes. It also outlines gentle management strategies to help reduce symptom burden. Key Points 1. The Lymphatic System’s Role in ME The lymphatic system…
PURPOSE This document explains how breathing difficulties, swallowing problems, and neurological symptoms fit within the ME‑ICC (Myalgic Encephalomyelitis International Consensus Criteria) framework. It provides context for these symptoms, how they relate to ME as a multi‑system condition, and outlines practical management approaches. KEY POINTS 1. ME as a Multi‑System Disease ME is a complex neuroimmune…